Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 3
1971 3
1972 1
1973 1
1976 1
1983 1
1989 1
1991 1
1992 4
1994 1
1995 4
1996 2
1997 1
1998 3
2000 1
2001 1
2003 5
2004 2
2005 4
2006 8
2007 9
2008 7
2009 6
2010 5
2011 6
2012 6
2013 13
2014 9
2015 7
2016 11
2017 8
2018 4
2019 6
2020 4
2021 4
2022 11
2023 11
2024 10
2025 17
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean osimoni e (1 results)?
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.
Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M, Molinelli E, Offidani A, Simonetti O. Diotallevi F, et al. Among authors: de simoni e. Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910. Int J Mol Sci. 2023. PMID: 36902341 Free PMC article. Review.
Does dermatoradiology exist?
Tagliati C, Rizzetto G, Molinelli E, De Simoni E, Fogante M, Argalia G, Lanni G, Rebonato A, Burroni L, Giuseppetti GM, Argalia G, Offidani A, Simonetti O. Tagliati C, et al. Among authors: de simoni e. Acta Dermatovenerol Alp Pannonica Adriat. 2024 Jun;33(2):107-108. Acta Dermatovenerol Alp Pannonica Adriat. 2024. PMID: 38918944 Free article. No abstract available.
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group. De Corso E, et al. Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26. Allergy. 2023. PMID: 37203259 Free article.
Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage.
De Corso E, Montuori C, Pipolo C, La Mantia I, Pasquini E, Ghidini A, Seccia V, Ottaviano G, Cantone E, Dané G, Garzaro M, Fadda GL, Torretta S, Anastasi F, Canevari FRM, Pagella F, Lucidi D, Cavaliere C, Pagliuca G, Maffei M, Bussu F, Corbò M, D Auria LM, De Maio G, Loperfido A, Gallo S, D Agostino G, Giannarelli D, Galli J; DUPIREAL Italian Study Group. De Corso E, et al. Allergy. 2026 Feb;81(2):388-401. doi: 10.1111/all.70032. Epub 2025 Aug 30. Allergy. 2026. PMID: 40884177
Bullous Pemphygoid and Novel Therapeutic Approaches.
D'Agostino GM, Rizzetto G, Marani A, Marasca S, Candelora M, Gambini D, Gioacchini H, De Simoni E, Maurizi A, Campanati A, Offidani A. D'Agostino GM, et al. Among authors: de simoni e. Biomedicines. 2022 Nov 8;10(11):2844. doi: 10.3390/biomedicines10112844. Biomedicines. 2022. PMID: 36359364 Free PMC article. Review.
Cisplatin-Induced Ototoxicity: Updates on Molecular Targets.
Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L. Gentilin E, et al. Among authors: simoni e. Trends Mol Med. 2019 Dec;25(12):1123-1132. doi: 10.1016/j.molmed.2019.08.002. Epub 2019 Aug 28. Trends Mol Med. 2019. PMID: 31473143 Review.
Regenerative medicine in hearing recovery.
Simoni E, Orsini G, Chicca M, Bettini S, Franceschini V, Martini A, Astolfi L. Simoni E, et al. Cytotherapy. 2017 Aug;19(8):909-915. doi: 10.1016/j.jcyt.2017.04.008. Epub 2017 May 19. Cytotherapy. 2017. PMID: 28532627 Review.
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.
Piraccini BM, Cedirian S, Pampaloni F, Rapparini L, Quadrelli F, Bruni F, Ala L, Acri MC, Rossi A, Pellacani G, Lacarrubba F, Dall'Oglio F, Micali G, Foggia L, Cantelli M, Nappa P, Diluvio L, Bianchi L, Luigi N, Bolzon A, Peris K, Caldarola G, Girolomoni G, Marangoni F, Bellinato F, Gisondi P, Silvi G, Prignano F, Pimpinelli N, Tomasini C, Barruscotti S, Simonetti O, de Simoni E, Ambrogio F, Foti C, Boccaletti V, Fraghì A, Marzano AV, Mattioli MA, Ferrucci S, Sechi A, Valtellini L, Barbareschi M, Gallo G, Ribero S, Quaglino P, Di Corteranzo IG, Balestri R, Pagliarello C, Caposiena RD, Zalaudek I, Vagnozzi E, Fargnoli MC, Caponio C, Rubegni P, Cinotti E, Trovato E, Romanelli M, Dini V, Manzo Margiotta F, Feliciani C, De Felici Del Giudice MB, Atzori L, Sanna S, Lembo S, Raimondo A, Magnano M, Argenziano G, Babino G, Fulgione E, Rongioletti F, Pesce N, Guida S, Guglielmo A, Schettini N, Starace M. Piraccini BM, et al. Among authors: de simoni e. J Eur Acad Dermatol Venereol. 2026 Feb;40(2):224-231. doi: 10.1111/jdv.70067. Epub 2025 Sep 23. J Eur Acad Dermatol Venereol. 2026. PMID: 40985491
186 results